Tremella Mushroom for Neuroprotection

Research suggests that Tremella fuciformis polysaccharides (TFPS) may have neuroprotective properties, based primarily on a 2019 narrative review that synthesized over a century's worth of accumulated studies on the compound's biological activities, including its antioxidant and anti-aging mechanisms thought to be relevant to brain health. A separate 2026 review examining mushrooms broadly in the context of infection-related neurological damage did not specifically highlight Tremella among the species it profiled, focusing instead on lion's mane, reishi, shiitake, and chaga, which introduces some uncertainty about how well Tremella's neuroprotective profile compares to better-studied mushroom species. The available evidence consists entirely of review literature rather than clinical trials or controlled human studies, meaning that while the mechanistic rationale for neuroprotection has been described in the literature, direct evidence from rigorous human research remains limited. Readers interested in this topic should be aware that a strong mechanistic or preclinical narrative does not necessarily translate to established clinical benefit, and the science in this area is still developing.